Literature DB >> 15016755

Histological categorisation of fibrotic cancer stroma in advanced rectal cancer.

H Ueno1, A M Jones, K H Wilkinson, J R Jass, I C Talbot.   

Abstract

BACKGROUND AND AIMS: Based on conflicting reports regarding the role of the fibrotic stromal response in cancer development--namely, that a desmoplastic reaction can favour either the host or the tumour--it is clear that the role of the stromal response is varied. We have classified the fibrotic stroma of rectal adenocarcinoma penetrating the muscularis propria, based on histologically identified stromal components.
METHODS: Three categories of stroma were used: mature-when the stroma was composed of mature collagen fibres (fine and elongated fibres into multiple layers); intermediate-when keloid-like collagen was intermingled with mature fibres; and immature-consisting of a myxoid stroma in which no mature fibres were included.
RESULTS: In a data set of 862 patients, 53% of patients had mature fibrotic cancer stroma, 33% had intermediate stroma, and 15% had immature stroma. Five year survival rates decreased as follows: mature stroma (80%), intermediate stroma (55%), and immature stroma (27%). The adverse tumour phenotype, tumour cell budding (conspicuous isolated cells or small clusters of cancer cells), was observed in the cancer fronts in tumours with unfavourable fibrotic stroma (p<0.0001). Based on multivariate analysis, categorised fibrotic stroma was selected as an independent prognostic parameter (hazard ratio 1.39; 95% confidence interval 1.17-1.64) together with tumour differentiation. By immunohistochemical examination, as maturation of the fibrotic stroma decreased, stromal T cells became significantly sparser. Furthermore, myofibroblasts were distributed extensively in immature fibrotic stroma compared with mature and intermediate fibrotic stroma.
CONCLUSION: The morphological categorisation of fibrotic cancer stroma highlights the role of the stromal response in relation to the behaviour and host immune reactions of rectal adenocarcinoma and would be a useful tool for predicting patient prognostic outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15016755      PMCID: PMC1774016          DOI: 10.1136/gut.2003.028365

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility.

Authors:  M Stoker; E Gherardi; M Perryman; J Gray
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

Review 2.  Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.

Authors:  R V Iozzo
Journal:  Lab Invest       Date:  1995-08       Impact factor: 5.662

3.  Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

Authors:  M Gleave; J T Hsieh; C A Gao; A C von Eschenbach; L W Chung
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

4.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

5.  Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer.

Authors:  T B Halvorsen; E Seim
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

6.  The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development.

Authors:  B Lieubeau; L Garrigue; I Barbieux; K Meflah; M Gregoire
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

7.  Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.

Authors:  H Nakanishi; K Oguri; K Takenaga; S Hosoda; M Okayama
Journal:  Lab Invest       Date:  1994-03       Impact factor: 5.662

8.  Desmoplasia and its relevance to colorectal tumour invasion.

Authors:  R E Hewitt; D G Powe; G I Carter; D R Turner
Journal:  Int J Cancer       Date:  1993-01-02       Impact factor: 7.396

9.  Paracrine control of differentiation in the alveolar carcinoma, A549, by human foetal lung fibroblasts.

Authors:  V Speirs; K P Ray; R I Freshney
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

10.  Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: comparison with granulation tissue reaction.

Authors:  H Ohtani; T Nagai; H Nagura
Journal:  Jpn J Cancer Res       Date:  1995-09
View more
  49 in total

1.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

2.  In rectal cancer, the type of desmoplastic response after preoperative chemoradiotherapy is associated with prognosis.

Authors:  Hideki Ueno; Eiji Shinto; Yojiro Hashiguchi; Hideyuki Shimazaki; Yoshiki Kajiwara; Takahiro Sueyama; Junji Yamamoto; Kazuo Hase
Journal:  Virchows Arch       Date:  2015-03-29       Impact factor: 4.064

3.  Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.

Authors:  Stéphanie Zunder; Priscilla van der Wilk; Hans Gelderblom; Tim Dekker; Christoph Mancao; Anna Kiialainen; Hein Putter; Rob Tollenaar; Wilma Mesker
Journal:  Cell Oncol (Dordr)       Date:  2019-05-17       Impact factor: 6.730

4.  Analysis of colorectal cancer morphology in relation to sex, age, location, and family history.

Authors:  Sam Ghazi; Ulrik Lindforss; Greger Lindberg; Elisabeth Berg; Annika Lindblom; Nikos Papadogiannakis
Journal:  J Gastroenterol       Date:  2012-01-18       Impact factor: 7.527

5.  Stimulated Raman histology: one to one comparison with standard hematoxylin and eosin staining.

Authors:  Barbara Sarri; Flora Poizat; Sandro Heuke; Julien Wojak; Florence Franchi; Fabrice Caillol; Marc Giovannini; Herve Rigneault
Journal:  Biomed Opt Express       Date:  2019-09-30       Impact factor: 3.732

6.  Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer.

Authors:  Katarzyna Jakubowska; Wojciech Kisielewski; Luiza Kańczuga-Koda; Mariusz Koda; Waldemar Famulski
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

7.  Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.

Authors:  Tadakazu Ao; Yoshiki Kajiwara; Keisuke Yonemura; Eiji Shinto; Satsuki Mochizuki; Koichi Okamoto; Suefumi Aosasa; Hideki Ueno
Journal:  Virchows Arch       Date:  2019-05-10       Impact factor: 4.064

Review 8.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

9.  Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.

Authors:  Ake Oldberg; Sebastian Kalamajski; Alexei V Salnikov; Linda Stuhr; Matthias Mörgelin; Rolf K Reed; Nils-Erik Heldin; Kristofer Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

10.  Evaluation of risk factors for lymph node metastasis in T2 lower rectal cancer to perform chemoradiotherapy after local resection.

Authors:  Hajime Ushigome; Masayuki Ohue; Masaki Kitamura; Shinichi Nakatsuka; Naoaki Haraguchi; Junichi Nishimura; Masayoshi Yasui; Hiroshi Wada; Hidenori Takahashi; Takeshi Omori; Hiroshi Miyata; Masahiko Yano; Shuji Takiguchi
Journal:  Mol Clin Oncol       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.